Chronic Pain Management: What Research Shows About an Undertreated Condition

Chronic pain is defined as pain that persists for three months or more beyond the expected period of healing and affects an estimated 50 million American adults. It is one of the most common reasons for seeking medical care and one of the leading causes of disability, reduced quality of life, and lost work productivity in the United States. Despite its prevalence and burden, chronic pain remains undertreated, misunderstood, and frequently dismissed in healthcare settings. Research on the neuroscience of chronic pain and on the effectiveness of different treatment approaches has advanced considerably, creating an opportunity to translate improved understanding into better care. The neuroscience of chronic pain has undergone a fundamental reconceptualization over the past three decades. The traditional biomedical model treated pain as a simple signal that tissue damage sends to the brain: more damage equals more pain. Research has revealed this model to be inadequate for understanding chronic pain. In many cases, chronic pain involves central sensitization, a process in which the nervous system amplifies pain signals and maintains pain perception even in the absence of ongoing tissue damage. The brain becomes, in a sense, stuck in a pain-producing mode that persists independently of peripheral injury. This reconceptualization has significant clinical implications. If chronic pain involves brain processes rather than simply tissue damage, treatments that target peripheral tissue, such as repeated surgeries or injections at the site of pain, may not address the underlying mechanism. Research on outcomes for common interventions such as spinal fusion surgery for low back pain, one of the most common elective surgeries in the United States, finds that long-term outcomes often do not improve beyond those achieved with conservative management. Yet these procedures continue to be widely performed. Psychological factors play a documented and important role in chronic pain. Catastrophizing, a cognitive pattern involving magnifying pain, ruminating on it, and feeling helpless to cope with it, is one of the strongest predictors of pain severity, disability, and poor treatment outcomes. Depression and anxiety are extremely common comorbidities with chronic pain, and the relationship is bidirectional: chronic pain increases risk for depression and anxiety, and these conditions amplify pain perception. Research on the neuroscience of these relationships finds overlapping brain circuits involved in pain processing and emotional regulation. Cognitive-behavioral therapy adapted for chronic pain, which addresses catastrophizing, activity avoidance, and unhelpful beliefs about pain, has the strongest evidence base among psychological interventions. Research including meta-analyses finds that CBT for chronic pain produces significant improvements in pain intensity, disability, and mood, with effects that persist at long-term follow-up. Acceptance and commitment therapy, which emphasizes living well with pain rather than eliminating it, has also demonstrated effectiveness in randomized trials. These approaches are recommended in clinical guidelines but are substantially underutilized in practice. Exercise and physical activity are among the most consistently supported treatments for multiple chronic pain conditions. Research on chronic low back pain, fibromyalgia, chronic fatigue syndrome with pain, and osteoarthritis consistently finds that appropriate exercise reduces pain, improves function, and supports psychological wellbeing. The mechanisms are multiple and include direct effects on musculoskeletal tissue, anti-inflammatory effects, release of endogenous pain-modulating substances, and psychological benefits of physical activity. The challenge in many clinical settings is that patients with chronic pain fear activity will worsen their condition, and healthcare providers sometimes reinforce this fear without evidence. Opioid analgesics were aggressively marketed and prescribed for chronic non-cancer pain beginning in the late 1990s, with claims of effectiveness and safety that were not supported by the evidence base that was available at the time. The opioid epidemic that followed was partly a consequence of this prescribing surge. Research on long-term opioid therapy for chronic non-cancer pain finds limited evidence of sustained benefit for most patients and substantial evidence of harms including dependence, overdose risk, hormonal effects, and paradoxical opioid-induced hyperalgesia, a condition in which opioid use increases pain sensitivity over time. Current clinical guidelines recommend opioids only for carefully selected patients who have not responded to other approaches. Interdisciplinary pain rehabilitation programs, which combine medical management, physical rehabilitation, and psychological treatment in coordinated programs, have the most consistent evidence for improving function and reducing disability among patients with the most severe and complex chronic pain. Randomized trials find that these programs outperform unimodal treatments on functional outcomes and often on pain outcomes as well. However, these programs are expensive, time-intensive, and not widely available, and insurance coverage is inconsistent. Social determinants of health shape chronic pain substantially. Research finds that people in lower-income jobs with more physical demands, people with less education and fewer economic resources, and people from racial and ethnic minority groups bear a disproportionate burden of chronic pain. These disparities reflect both differences in exposure to occupational and environmental pain risks and differences in access to effective treatment. Addressing chronic pain at the population level requires attention to these structural factors alongside clinical innovation. The research supports a multimodal, biopsychosocial approach to chronic pain that addresses neurological, psychological, social, and physical dimensions simultaneously. The gap between this evidence-informed approach and the predominantly biomedical and pharmaceutical approach that still dominates many clinical settings represents a significant opportunity to reduce the enormous burden that chronic pain imposes on individuals and on the healthcare system.